Antibiotic innovation has slowed, allowing drug resistance to catch up, but there is still hope for the future of anti-infectives.
A look at the processes of immunity and ocular inflammation,
and new avenues for disease therapy.
How different drug formulations and dosing regimens may help ensure that patients take their medicine.
A look at the value and utility of a range of diagnostic
techniques and technology for anterior segment disease.
When a patient is taking drugs systemically, here are the ocular
adverse events to be on the lookout for.
Here’s what you should know about treating ocular Hyperemia and its underlying cause.
How models of disease, carried out in the clinic, can yield
useful information about an ailment and treatments for it.
Ophthalmic Product Development Insights
Theme of ‘life-changing research’ provides current data on retina, glaucoma, dry eye, and more
Highlights from the papers and posters of ARVO’s first foray
outside of the balmy borders of Florida.